Detalhe da pesquisa
1.
Statin persistence and adherence among older initiators: A nationwide cohort study using the national health insurance claims database in Japan.
Pharmacoepidemiol Drug Saf
; 32(8): 873-885, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960485
2.
Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study.
Biol Pharm Bull
; 46(11): 1548-1557, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914357
3.
A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies.
BMC Med Res Methodol
; 21(1): 214, 2021 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657592
4.
Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries.
Pharmacoepidemiol Drug Saf
; 24(8): 858-64, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907076
5.
Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study.
Pharmacoepidemiol Drug Saf
; 22(9): 915-24, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23696036
6.
High SLC20A1 Expression Indicates Poor Prognosis in Prostate Cancer.
Cancer Diagn Progn
; 3(4): 439-448, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405223
7.
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.
PLoS One
; 17(5): e0268799, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605014
8.
High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.
Cancer Diagn Progn
; 2(4): 429-442, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35813014
9.
Event Monitoring and Evaluation by Community Pharmacists in Japan: A Pilot Study on Fenofibrate and Pemafibrate.
Curr Drug Saf
; 17(4): 350-356, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35209830
10.
High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.
Anticancer Res
; 42(7): 3299-3312, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790283
11.
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
Jpn J Clin Oncol
; 41(1): 32-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20798232
12.
Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan.
Pharmacoepidemiol Drug Saf
; 20(6): 643-52, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21425207
13.
Safety of elobixibat and lubiprostone in Japanese patients with chronic constipation: a retrospective cohort study.
Expert Opin Drug Saf
; 20(12): 1553-1558, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281471
14.
Evaluation of rapid drug safety communication materials for patients in Japan.
Drug Discov Ther
; 15(2): 101-107, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33952763
15.
High SLC20A1 Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers.
Anticancer Res
; 41(1): 43-54, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419798
16.
Real-world evidence of population differences in allopurinol-related severe cutaneous adverse reactions in East Asians: A population-based cohort study.
Clin Transl Sci
; 14(3): 1002-1014, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382928
17.
Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.
Oncol Lett
; 22(1): 547, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34093768
18.
GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.
Anticancer Res
; 41(12): 5959-5971, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848450
19.
Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
Res Social Adm Pharm
; 16(7): 958-966, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839583
20.
High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.
PLoS One
; 15(7): e0235747, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658903